Pérez-Fidalgo JA - Search Results

1

Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?

Pérez-Fidalgo JA, Pimentel P, Caballero A, Bermejo B, Barrera JA, Burgues O, Martinez-Ruiz F, Chirivella I, Bosch A, Martínez-Agulló A, Lluch A. Pérez-Fidalgo JA, et al. Breast. 2011 Dec;20(6):548-54. doi: 10.1016/j.breast.2011.06.005. Epub 2011 Aug 3. Breast. 2011. PMID: 21816613 Free article.

2

Analysis of clinical prognostic factors for survival and time to progression in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapy.

Yuste AL, Aparicio J, Segura A, López-Tendero P, Gironés R, Pérez-Fidalgo JA, Díaz R, Calderero V. Yuste AL, et al. Clin Colorectal Cancer. 2003 Feb;2(4):231-4. doi: 10.3816/CCC.2003.n.004. Clin Colorectal Cancer. 2003. PMID: 12620142

3

Parotid gland metastasis of a breast cancer.

Perez-Fidalgo JA, Chirivella I, Laforga J, Colio JM, Blanes MD, Baydal R, Roselló S, De-la-Morena E, Lluch A. Perez-Fidalgo JA, et al. Clin Transl Oncol. 2007 Apr;9(4):264-5. doi: 10.1007/s12094-007-0051-2. Clin Transl Oncol. 2007. PMID: 17462982

4

[Breast cancer metastases in the iris: does treatment modifies natural history of the illness?].

Pérez-Fidalgo JA, Vila Arteaga J, Chirivella González I, Martínez Belda R, Bermejo de Lasheras B, Roselló Keranën S, Fons Moreno A, Lluch Hernández A. Pérez-Fidalgo JA, et al. An Med Interna. 2008 Apr;25(4):178-80. doi: 10.4321/s0212-71992008000400006. An Med Interna. 2008. PMID: 18604334 Spanish.

5

Impact of a mammography screening programme on the breast cancer population of the Region of Valencia (Spain).

Pérez-Fidalgo JA, Miranda J, Chirivella I, Ibáñez J, Bermejo B, Pons C, Melchor I, Santaballa A, Martínez-Ruiz F, Lluch A, Salas D. Pérez-Fidalgo JA, et al. Clin Transl Oncol. 2008 Nov;10(11):745-52. doi: 10.1007/s12094-008-0281-y. Clin Transl Oncol. 2008. PMID: 19015071

6

Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens.

Pérez-Fidalgo JA, Roselló S, García-Garré E, Jordá E, Martín-Martorell P, Bermejo B, Chirivella I, Guzman C, Lluch A. Pérez-Fidalgo JA, et al. Breast Cancer Res Treat. 2010 Feb;120(1):245-51. doi: 10.1007/s10549-009-0426-x. Epub 2009 Jul 3. Breast Cancer Res Treat. 2010. PMID: 19575291

7

Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.

Eroles P, Bosch A, Pérez-Fidalgo JA, Lluch A. Eroles P, et al. Cancer Treat Rev. 2012 Oct;38(6):698-707. doi: 10.1016/j.ctrv.2011.11.005. Epub 2011 Dec 16. Cancer Treat Rev. 2012. PMID: 22178455 Review.

8

Integrating radical local treatment of the primary in the management of stage IV breast cancer. When is the best moment for the resection of the primary tumor?

Perez-Fidalgo JA, Caballero A, Lluch A. Perez-Fidalgo JA, et al. Eur J Surg Oncol. 2012 Aug;38(8):643-4. doi: 10.1016/j.ejso.2012.03.003. Epub 2012 Apr 5. Eur J Surg Oncol. 2012. PMID: 22483703 No abstract available.

9

An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer.

Pérez-Fidalgo JA, Eroles P, Ferrer J, Bosch A, Burgués O, Martínez F, Bermejo B, Lluch A, González-Angulo AM. Pérez-Fidalgo JA, et al. Breast. 2013 Oct;22(5):974-9. doi: 10.1016/j.breast.2013.05.014. Epub 2013 Jun 25. Breast. 2013. PMID: 23809906

10

Zoledronic acid in the treatment of metastatic breast cancer.

Lluch A, Cueva J, Ruiz-Borrego M, Ponce J, Pérez-Fidalgo JA. Lluch A, et al. Anticancer Drugs. 2014 Jan;25(1):1-7. doi: 10.1097/CAD.0000000000000020. Anticancer Drugs. 2014. PMID: 24100278 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters